High Catastrophizing in Subjects With Painful Mesh Complications Leads to Worse Outcomes.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 25 04 2018
revised: 30 05 2018
accepted: 31 05 2018
pubmed: 5 8 2018
medline: 16 5 2019
entrez: 5 8 2018
Statut: ppublish

Résumé

To identify the rate of catastrophizing in a cohort of subjects with chronic pain after self-reported mesh complications and identify interactions of catastrophization with other patient factors, such as age, number of pelvic surgeries, and intent to sue. Catastrophizing has been shown to be a risk factor for chronicity of pain, disability, and depression. The pain catastrophization scale (PCS) identifies patients likely to have an exaggerated, negative thought process in response to pain. Subjects throughout the United States with self-described complications of vaginal mesh completed an internet-based, anonymous survey, featuring multiple standardized questionnaires including the PCS and female Genitourinary Pain Index (GUPI). A previously defined threshold score of >30 on the PCS defined high-pain catastrophizing. Statistical analysis was performed using χ² test and t test for categorical and continuous variables, respectively. Ninety of 167 participants (54%) were found to have high-pain catastrophizing. Age, intent to sue, or number of previous pelvic surgeries did not correlate with high catastrophization. Subjects who catastrophized were significantly more likely to have a higher overall GUPI score (35.0 vs 30.5, P < .001), which came from increases in the pain (18.0 vs 14.2, P < .001) and quality of life (11.0 vs 9.5, P < .001) GUPI subdomains. Subjects with self-described mesh complications have a high rate of pain catastrophizing associated with significantly worse quality of life and higher pain. Identifying high catastrophizing patients in the setting of chronic pelvic pain from mesh complications may help guide treatment and be an indicator for early or adjunctive psychosocial intervention.

Identifiants

pubmed: 30076941
pii: S0090-4295(18)30757-X
doi: 10.1016/j.urology.2018.05.050
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

83-90

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Auteurs

Ariel Moradzadeh (A)

Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.

Juzar Jamnagerwalla (J)

Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.

Karyn S Eilber (KS)

Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.

Jennifer T Anger (JT)

Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.

A Lenore Ackerman (A)

Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA. Electronic address: A.Lenore.Ackerman@cshs.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH